
SUEWALLST PODCAST
Fraud, whistleblowers, and consequences—explained.
Listen to the Securities Legal Beat!
Track and Claim Your Money.
Tune in to the stories behind shareholder wins and corporate fallout — learn how to track, claim, and protect what's yours.
WHAT'S NEW
Active Case![ImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update](https://media.suewallst.com/cms-dev/IBRX_b3f81bce77.png)
![ImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update](https://media.suewallst.com/cms-dev/IBRX_b3f81bce77.png)
ImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update
ImmunityBio, Inc. (IBRX) faces a class action alleging it misled investors by overstating Anktiva’s cancer treatment potential and approved uses, following an FDA warning letter and stock decline.

Missing Numbers, Broken Trust: What Investors Need to Know
BREAKING: Wall Street execs shocked to discover that “trust” is not a legal defense. When the numbers go missing, it’s Main Street that pays the price. Know the signs. Know your rights.
